ASCIA Action, First Aid, Management, Transfer, Travel and Treatment Plans
ASCIA Action Plans for Anaphylaxis (RED)
Current ASCIA Action Plans are the 2023 versions. However, prior versions (2022 and 2021) are still valid for use in 2023. ASCIA Action Plans do not expire, and therefore the plan is still valid beyond the date of review, which is a guide for patients to see their doctor. For further information about ASCIA Action Plans go to www.allergy.org.au/hp/anaphylaxis/action-plans-for-allergic-reactions-faq
ASCIA Action Plan for Anaphylaxis (RED) 2023
The general version of this plan is for people with allergies who have been prescribed either brand of adrenaline injector devices.
Device specific versions are available below.
These plans are not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.
ASCIA Action Plan for Drug (Medication) Allergy (GREEN) 2023
This plan is provided to people with drug (medication) allergies who are not usually prescribed an adrenaline injector, because accidental exposure to drugs can mostly be avoided. They are usually recommended to wear medical identification, to avoid exposure to drugs used in medical procedures.
ASCIA First Aid Plans for Anaphylaxis (ORANGE)
This plan can be used as a poster or stored with general use adrenaline injectors.
A version of this plan for use by crew on aircraft is available upon request.
For translated versions of the ASCIA First Aid for Anaphylaxis go to www.allergy.org.au/hp/anaphylaxis#ta5
ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2023
The general version of this plan can be used as a poster or stored with either brand of general use adrenaline injector devices.
Device specific versions are available below.
ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2023 Pictorial Poster
This plan can be used as a poster or stored with general use adrenaline injectors.
IMAGE CURRENTLY BEING FINALISED
ASCIA Travel Plan for people at risk of anaphylaxis 2023
This plan should be used with an ASCIA Action Plan for Anaphylaxis.
ASCIA Action Plan for FPIES (food protein-induced enterocolitis syndrome)
ASCIA SCIg (subcutaneous immunoglobulin) Treatment Plan
ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)
ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)
ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy
ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy
Content updated June 2023
ASCIA Action Plans,
Treatment Plans and
Checklists
Site last updated: 4 Jun 2023
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Information Partner
